Pharmena

Pharmena Tangible Book Value per Share

The Tangible Book Value per Share of Pharmena (PHR.WA) as of Oct 17, 2026 is 0.87 PLN. In the previous year, Tangible Book Value per Share was 1.11 PLN — a change of -22.32% (lower).

Tangible Book Value per Share

0.87PLN

YoY

-22.32%

Last updated:

Tangible Book Value per Share of Pharmena is 2025 0.87 PLN. Tangible Book Value per Share of Pharmena was 2024 1.11 PLN. It decreases by -22.32% lower compared to the previous year.

The Pharmena Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.06 PLN
Jan 1, 2019
0.36 PLN
Jan 1, 2020
-0.10 PLN
Jan 1, 2021
-0.52 PLN
Jan 1, 2022
-0.58 PLN
Jan 1, 2023
2.02 PLN
Jan 1, 2024
1.11 PLN
Jan 1, 2025
0.87 PLN
The Pharmena Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.87PLN-22.32%
1.11PLN-44.85%
2.02PLN-447.01%
-0.58PLN+11.30%
-0.52PLN+408.81%
-0.10PLN-128.31%
0.36PLN+498.82%
0.06PLN-73.66%
0.23PLN-49.91%
0.46PLN-33.71%
0.69PLN-35.64%
1.08PLN-39.91%
1.79PLN+93.83%
0.93PLN-59.01%
2.26PLN+4.00%
2.17PLN-1.17%
2.20PLN+2.66%
2.14PLN+988.30%
0.20PLN+11.33%
0.18PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pharmena Stock analysis

What does Pharmena do? Pharmena SA is a company based in Lodz, Poland, operating within the Consumer Staples sector, specifically in the Consumer products industry. The company has 24 employees and went public on August 25, 2008. Pharmena SA develops and markets products based on a patented active substance called 1-MNA, which is described as physiological and natural. The company's product range includes Dermena, a line targeting hair loss; Dermena Plus, a shampoo designed to reduce dandruff symptoms and prevent excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care; Thermi, a gel for treating thermal burns and sunburns; and Revium, a line of anti-wrinkle treatments. Pharmena SA collaborates with research centers across Europe, the United States, and Canada on multidirectional research and application studies. The company maintains a wholly owned subsidiary, Cortria Corporation, which is based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in Pharmena SA, and Pelion SA is identified as the main shareholder. The company's website is www.pharmena.eu. Pharmena is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmena stock

Tangible Book Value per Share of Pharmena is 0.87 PLN in 2025.

Tangible Book Value per Share of Pharmena changed from 1.11 PLN to 0.87 PLN, representing a -22.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Pharmena since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Pharmena

All Key Metrics — Pharmena